Development of a competitive ELISA for the quantification of F5 conjugate in HER2-targeted STEALTH immunoliposome doxorubicin in plasma samples

Ran Hu; Rebecca Davis; Yongjin Yao; Yaodong Xu
December 2006
Analytical & Bioanalytical Chemistry;Dec2006, Vol. 386 Issue 6, p1657
Academic Journal
HER2 (human epidermal growth factor receptor 2, erbB2, or neu) is overexpressed by a large number of tumor types and has been identified as an important target for cancer therapy. F5 is a single-chain human antibody fragment that recognizes HER2 receptor and is covalently conjugated to PEGylated lipid to form F5 conjugate (F5CG) in the product HER2 targeted STEALTH immunoliposome doxorubicin. Here we described the method development of a competitive enzyme-linked immunosorbent assay (ELISA) for the determination of total concentration of F5 conjugate in plasma samples. The method involved the biotinylation of F5CG, detergent treatment of plasma sample to solubilize F5CG into monomeric form, and competitive ELISA for solubilized F5CG competitively binding to anti-F5CG antibody with biotinylated F5CG for the determination of total F5CG in plasma. The detection range of this method was from 0.2 ng/mL to 125 ng/mL for F5CG in plasma. The lower limit of quantification (LLOQ) was 0.2 ng/mL. This method was established and used for the measurement of F5CG concentration to provide information about F5CG circulation after the administration of immunoliposome in preclinical studies. [Figure not available: see fulltext.]


Related Articles

  • EIA.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p730 

    A definition of the acronym "EIA," which is enzyme immunoassay, is presented.

  • enzyme immunoassay.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p785 

    An encyclopedia entry for "enzyme immunoassay" is presented.

  • Clinical significance of serum hepatocyte growth factor and epidermal growth factor gene somatic mutations in patients with non-squamous non-small cell lung cancer receiving gefitinib or erlotinib. Masago, Katsuhiro; Togashi, Yosuke; Fujita, Shiro; Sakamori, Yuichi; Okuda, Chiyuki; Kim, Young; Mio, Tadashi; Mishima, Michiaki // Medical Oncology;Sep2012, Vol. 29 Issue 3, p1614 

    A study of patients with advanced non-squamous non-small cell lung cancer (NSCLC) evaluated epidermal growth factor receptor (EGFR) mutation status and serum hepatocyte growth factor (HGF) for their associations with response to gefitinib therapy and prognostic impact. An enzyme-linked...

  • Epidermal growth factor receptor as a potential therapeutic target in triple-negative breast cancer. Corkery, B.; Crown, J.; Clynes, M.; ODonovan, N. // Annals of Oncology;May2009, Vol. 20 Issue 5, p862 

    Background: No proven targeted therapy is currently available for the treatment of triple-negative breast cancer (TNBC). Epidermal growth factor receptor (EGFR) is frequently overexpressed in TNBC. We studied the activity of EGFR antagonists alone, and in combination with chemotherapy, in TNBC...

  • GPR30 as an initiator of tamoxifen resistance in hormone-dependent breast cancer. Zhiqiang Mo; Manran Liu; Fangfang Yang; Haojun Luo; Zhenhua Li; Gang Tu; Guanglun Yang // Breast Cancer Research;2013, Vol. 15 Issue 6, p2 

    Introduction Tamoxifen is widely used to treat hormone-dependent breast cancer, but its therapeutic benefit is limited by the development of drug resistance. Here, we investigated the role of estrogen G-protein coupled receptor 30 (GPR30) on Tamoxifen resistance in breast cancer. Methods Primary...

  • Shed Syndecan-1 is involved in chemotherapy resistance via the EGFR pathway in colorectal cancer. Liu, R; Zhou, L; Deng, T; Ba, Y; Wang, X; Chen, Y; Zuo, D; Ren, L; Li, W; He, Y; Ying, G // British Journal of Cancer;11/11/2014, Vol. 111 Issue 10, p1965 

    Background:Syndecan-1 (Sdc-1) shedding induced by matrix metalloproteinase-7 (MMP-7) and additional proteases has an important role in cancer development. However, the impact of Sdc-1 shedding on chemotherapeutic resistance has not been reported.Methods:We examined Sdc-1 shedding in colorectal...

  • Improved diagnostic test for tuberculosis in badgers.  // Veterinary Record: Journal of the British Veterinary Association;9/27/2003, Vol. 153 Issue 13, p379 

    Introduces an article describing a trial of a new multi-antigen test, the Dachs tuberculosis-enzyme-linked immunosorbent assay, published in the September 2003 issue of 'The Veterinary Record.'

  • ELISA.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p743 

    A definition of the acronym "ELISA," is presented, which stands for Enzyme-linked immunosorbent assay.

  • SEROPREVALENCE OF NEOSPORA CANINUM INFECTION ON DAIRY CATTLE IN FARMS FROM SOUTHERN ROMANIA. Mitrea, Ioan Liviu; Enachescu, Violeta; Radulescu, Ruxandra; Ionita, Mariana // Journal of Parasitology;Feb2012, Vol. 98 Issue 1, p69 

    Neospora caninum, a coccidian parasite closely related to Toxoplasma gondii, is one of the major causes of abortion in cattle worldwide. Conventional serological techniques, such as the indirect fluorescent antibody test and enzyme-linked immunosorbent assay (ELISA), are routinely used in adult...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics